Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of Medical Virology"
DOI: 10.1002/jmv.24590
Abstract: Anti‐JCV antibody status is used for PML‐risk‐stratification in MS patients before and during Natalizumab therapy. JCV antibodies can be detected in around 60% of MS patients, however, only a small proportion actually develop PML. As…
read more here.
Keywords:
measles rubella;
jcv;
rubella varicella;
varicella zoster ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Indian Pediatrics"
DOI: 10.1007/s13312-017-1209-9
Abstract: A quadrivalent MMRV (measles-mumps-rubella-varicella) combination vaccine has recently been launched in India. This vaccine is highly immunogenic, with seroconversion rates against all antigens reaching 96.6-100% at 42 to 56 days after the second vaccine dose…
read more here.
Keywords:
rubella varicella;
vaccine;
mumps rubella;
measles mumps ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "mSphere"
DOI: 10.1128/msphere.00112-19
Abstract: The critical evaluation of immunization programs is key to identifying areas of suboptimal vaccination coverage, monitoring activities, and aiding development of public health policy. For evaluation of vaccine effectiveness, direct antibody binding assay methods, including…
read more here.
Keywords:
health;
measles mumps;
validation;
rubella varicella ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "F1000Research"
DOI: 10.12688/f1000research.26523.1
Abstract: Vaccine surveillance programs are crucial for the analysis of the vaccine's safety profile and the guidance of health policies. The Epidemiological Observatory of the Italian Apulia Region carried out an active surveillance program of adverse…
read more here.
Keywords:
measles mumps;
pharmacovigilance;
rubella varicella;
mumps rubella ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Acta medica Okayama"
DOI: 10.18926/amo/63718
Abstract: Vaccine-preventable disease (VPD) infections are more severe in immunocompromised hosts. Vaccination against measles, mumps, rubella, and varicella zoster (VZV) (MMRV) is therefore recommended for hematopoietic stem cell transplantation (HCT) recipients. However, studies on adult HCT…
read more here.
Keywords:
rubella varicella;
stem cell;
varicella zoster;
hematopoietic stem ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Vaccines"
DOI: 10.3390/vaccines11030656
Abstract: Patients after hematopoietic stem cell transplantation (HSCT) are vulnerable to infections due to severe immunosuppression. Live-attenuated vaccines are contraindicated for two years after HSCT. The aim of this study was to assess the persistence of…
read more here.
Keywords:
antibodies measles;
persistence;
rubella varicella;
measles mumps ... See more keywords